Home > PB Ratio > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
PB (Price/Book ) Ratio

The Current P/B Ratio of LINCOLN PHARMACEUTICALS is 1.84.

Share Price ₹544.3Mar 10,2025
Market Cap ₹1,088.5 Cr
Book Value₹592.8 CrMar2024 - Consolidated Results
Price/Book 1.84xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PB (Price/Book ) ratio of LINCOLN PHARMACEUTICALS

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of LINCOLN PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹1,088.5 Cr] as on Mar 10,2025

(/) Book Value [ ₹592.8 Cr] based on Mar2024 - Consolidated Results

(=) P/B Ratio [ 1.84x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for LINCOLN PHARMACEUTICALS , the investors are currently willing to pay '1.84 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of LINCOLN PHARMACEUTICALS !

The chart below summarizes the trend in P/B Ratio of LINCOLN PHARMACEUTICALS over the last five years.

Historical PB (Price/Book ) ratio chart of LINCOLN PHARMACEUTICALS


PB Ratio Performance Analysis for LINCOLN PHARMACEUTICALS

- LINCOLN PHARMACEUTICALS 's latest p/b ratio is 1.84x.

- LINCOLN PHARMACEUTICALS 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.37x.

- LINCOLN PHARMACEUTICALS 's operated at median p/b ratio of 1.35x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, LINCOLN PHARMACEUTICALS 's p/b ratio peaked in Mar2024 at 1.98x.

- LINCOLN PHARMACEUTICALS 's p/b ratio hit its five-year low in Mar2020 of 0.85x.


How does LINCOLN PHARMACEUTICALS 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
LINCOLN PHARMACEUTICALS 592.841.841,088.5
SUN PHARMACEUTICAL INDUSTRIES LTD63,666.806.07386,569.0
DIVIS LABORATORIES LTD13,571.0010.78146,318.0
CIPLA LTD26,619.904.44118,110.0
TORRENT PHARMACEUTICALS LTD6,856.1515.16103,926.0
DR REDDYS LABORATORIES LTD28,123.503.3293,471.5
MANKIND PHARMA LTD9,339.849.9893,257.2
ZYDUS LIFESCIENCES LTD19,829.504.5389,876.8
LUPIN LTD14,175.806.4791,732.8
AUROBINDO PHARMA LTD29,842.802.1363,472.9
ABBOTT INDIA LTD3,658.7317.7965,100.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs LINCOLN PHARMACEUTICALS 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 1.84x
Max industry PB 17.79x
Median industry PB 6.07x
Average industry PB 7.50x



You may also like the below Video Courses